FunGen-AD researcher Richard Mayeux is part of a Columbia University research team investigating blood tests for Alzheimer’s disease. A recent study of older adults found that, when used in combination with memory tests, these blood tests could help physicians correctly identify patients with Alzheimer’s disease. The tests may also be able to detect preclinical Alzheimer’s disease in some patients. Availability of a blood test for Alzheimer’s disease could be particularly helpful in low-resource areas, which often lack access to brain imaging technologies but are home to more than half of people living with dementia worldwide.
This research was partially supported by FunGen-AD grant R01AG067501 and published in JAMA Network Open. You can read more about the research findings at the following links:
- Blood Tests May Help Physicians in Low-Resource Environments Diagnose Alzheimer Disease (Columbia University)
- Blood tests may help physicians in low-resource environments diagnose Alzheimer’s disease (Medical Xpress)
- Blood Tests Can Help Physicians Correctly Diagnose Alzheimer’s In Low-Resource Environments (LabMedica)
- Blood Tests Could Aid Alzheimer’s Diagnosis in Low-Resource Areas (Mirage News)